Interesting comments from Professor D’Agistino regarding how a Ketogenic Diet helps Angelmans Syndrome even though it’s a genetic disorder. A keto diet has been used for epilepsy for over 100 years.
Would it help for the other genetic disorders that NEU are planning to address.
from the 6 minute mark!
Ann: FDA approval for Angelman IND and Phase 2 trial, page-12
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |